Rhythm Pharmaceuticals, Inc. RYTM Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s interest coverage?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported interest coverage of -10× in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s interest coverage changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s interest coverage decreased by 19.8% year-over-year, from -8.3× to -10×.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s interest coverage?
- Over 3 years (2022 to 2025), Rhythm Pharmaceuticals, Inc.'s interest coverage has grown at a -35.3% compound annual growth rate (CAGR), from -34.4× to -9.3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.